Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025ChildrenOpen Access

Revisiting Hepatic Fibrosis Risk in Congenital Heart Disease: Insights from Non-Invasive Markers and Echocardiography

View Full Paper
Ask AI
Bookmark
Share

Authors

FYFusako YamazakiHKHiroteru KamimuraSESaori Endo

Discussion

Loading...

Member takes

Overview

Observational analysis shows hepatic fibrosis risk in congenital heart disease patients, highlighting non-invasive markers and echocardiographic factors.

Key Points

  • The Fontan circulation group had the highest levels of APRI, indicating significant hepatic fibrosis risk.
  • Postoperative TOF patients require careful monitoring for potential progression to cirrhosis.
  • Non-invasive markers like APRI and γ-GTP are crucial in early detection of hepatic fibrosis among patients.
  • Echocardiographic parameters revealed strong associations with both fibrosis severity and non-invasive biomarkers.

Cite This Study

Yamazaki et al. (2025) studied this question.

synapsesocial.com/papers/68c2384fb210217d64776ee0https://doi.org/10.3390/children12091131
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Non-invasive fibrosis tools lack clinical utility for identifying advanced fibrosis in Fontan-associated liver disease: a retrospective cohort study2025 · 3 citations
  2. 2Fontan‐Associated Liver Disease: Trends Over Time and Relationship With Outcomes2025 · 1 citations
  3. 3Reply: Unifying FALD assessment—A call to arms2025
  4. 4Doppler ultrasound and 2D shear wave ultrasound elastography for liver fibrosis evaluation in Fontan-associated liver disease2025 · 2 citations
  5. 5Unifying FALD assessment—A call to arms2025 · 1 citations